The protective effects of resveratrol against changes in blood platelet thiols induced by platinum compounds

Journal of Physiology and Pharmacology

Volumn 55, Issue 2, 2004, Pages 467-476

  Olas, B ^a   Wachowicz, B ^a   Bald, E ^a   Glowacki R ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Blood platelets; Cisplatin; Glutathione; Resveratrol; Thiols

Indexed keywords

ANTIOXIDANT; CELL PROTEIN; CISPLATIN; CISPLATIN DERIVATIVE; CYSTEINE; CYSTEINYLGLYCINE; GLUTATHIONE; PLATINUM DERIVATIVE; RESVERATROL; SELENIUM CISPLATIN CONJUGATE; SELENIUM DERIVATIVE; THIOL GROUP; UNCLASSIFIED DRUG;

ARTICLE; BLOOD TOXICITY; CELL ISOLATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; THROMBOCYTE DYSFUNCTION;

EID: 3142512420     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bick RL, Strauss JF, Frenkel EP. Thrombosis and hemorrhage in oncology patients. Hematology/Oncology Clinics North America 1996; 10: 875-907.
2. Goad KE, Gralnick HR. Coagulation disorders in cancer. Complic Cancer 1996; 10: 457-484.
3. Keppler BK. Metal complexes in cancer chemotherapy. General remarks. In: Keppler BK, ed. Metal complexes in cancer chemotherapy. Weinheim: VCH 1993, 1-8.
4. Olas B, Wachowicz B. Cisplatin-induced changes of biological activity of blood platelets; thiol-related mechanisms. Anti-Cancer Drugs 1996; 7: 476-482.
5. Olas B, Wachowicz B, Buczyfiski A. Adhesion of blood platelets to collagen and fibrinogen after treatment with cisplatin and its complex with glutathione. Cytobios 2000; 102: 75-84.
6. Wachowicz B, Kustrofi J. Effect of cisplatin on lipid peroxidation in pig blood platelets. Cytobios 1992; 70: 41-47.
7. Wachowicz B. Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate. Cytobios 1993; 75: 157-162.
8. Wachowicz B, Olas B. Changes of platelet cytoskeleton induced by cisplatin in the relation to platelet activation. Biomed Lett 1995; 52: 181-190.
9. 3) in blood platelets. General Physiol Biophys 1997; 16: 263-272.
10. 3)) on oxidative stress in blood platelets measured by chemiluminescence method. J Physiol Pharmacol 1999; 50: 299-308.
11. Olas B, Wachowicz B. Modulation of cisplatin toxicity in blood platelets by glutathione depletion. Anti-Cancer Drugs 1998; 9: 473-478.
12. Olas B, Wachowicz B. Inhibitory effects of cisplatin and its conjugate with glutathione on blood platelet activation. Platelets 1998; 9: 69-72.
13. Olas B, Żbikowska HM. Changes of glutathione S-transferase (GST) activity in blood platelets induced by cisplatin. Biomed Lett 1999; 59: 93-99.
14. 2) via capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 2002; 23: 81-87.
15. Kappusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, Mitchell JB. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 2002; 62: 307-312.
16. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Rad Biol Med 2001; 30: 1191-1212.
17. Hansen JM, Choe HS, Carney EW, Harris C. Differential antioxidant enzyme activities and glutathione content between rat and rabbit conceptuses. Free Rad Biol Med 2001; 30: 1078-1088.
18. Inayama T, Oka J, Kashiba M, Saito M, Higuchi M, Umegaki K, Yamamoto Y, Matsuda M. Moderate physical exercise induces the oxidation of human blood protein thiols. Life Sci 2002; 70: 2039-2046.
19. Martin C, Martinez R, Navarro R, Ruiz-Sanz JI, Lacort M, Ruiz-Larrea MB. tert-Butyl hydroperoxide-induced lipid signalling in hepatocytes: involvement of glutathione and free radicals. Bioch Pharm 2001; 62: 705-712.
20. Bertelli AA, Giovannini L, Bernini W, Migliori M, Fregoni M, Baveresco L, Bertelli A. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 1996; 22: 61-63.
21. Bertelli AA, Giovannini L, Giannessi DZ, Migliori M, Bernini W, Fregoni M, Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995; 17: 1-3.
22. Daniel O, Meier MS, Schlatter J, Schlahter J, Frischhnecht P. Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides. Environmental Health Perspectives 1999; 17: 109-114.
23. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CV, Beecher CHWW, Fong HHS, Farnsworth NR, Monn RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-219.
24. Lin JK, Tsai SH, Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Rep China 1999; 23: 99-106.
25. Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000; 59: 865-870.
26. Olas B, Żbikowska HM, Wachowicz B, Krajewski T, Buczyfiski A, Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Polon 1999; 46: 961-966.
27. Olas B, Wachowicz B, Saluk-Juszczak J, Zielifiski T, Kaca W, Buczyfiski A. Antioxidant activity of resveratrol in endotoxin - stimulated blood platelets. Cell Biol Toxicol 2001; 17: 117-125.
28. Żbikowska HM, Olas B, Wachowicz B, Krajewski T. Response of blood platelets to resveratrol. Platelets 1999; 10: 247-252.
29. Żbikowska HM, Olas B. Antioxidants with carcinostatic activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion. J Physiol Pharmacol 2000; 3: 513-520.
30. Walkowiak B, Michalak E, Koziolłkiewicz W, Cierniewski CS. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thrombos Res 1989; 56: 763-766.
31. Ando Y, Steiner M. Sulfhydryl and disulfide groups of platelet membranes: determination of disulfide groups. Biochim Biophys Acta 1973; 311: 26-37.
32. Ando Y, Steiner M. Sulfhydryl and disulfide groups of platelet membranes: determination of sulfhydryl groups. Biochim Biophys Acta 19973; 311: 38-44.
33. Glłowacki R, Wójcik K, Bald E. Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromat 2001; 914: 29-35.
34. Hervig T, Mansoor MA, Farstad M. Endogenous glutathione and platelet function in platelet concentrates stored in plasma or platelet additive solution. Transf Med 2001; 11: 97-104.
35. Lee YW, Ha MS, Kim YK. Role of reactive oxygen species and glutathione in inorganic mercury-induced injury in human glioma cells. Neurochem Res 2002; 26: 1187-1193.
36. Nordberg J, Amer ESJ. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Rad Biol Med 2001; 31: 1287-1312.
37. Rovere FD, Granata A, Saija A, Broccio M, Tomaino A, Zirilli A, De Caridi G, Broccio G. -SH groups and glutathione in cancer patient's blood. Anticancer Res 2000; 20: 1595-1598.
38. Essex DW, Li M. Redox control of platelet aggregation. Biochemistry 2003; 42: 129-36.
39. Arts MJTJ, Haenen GRMM, Wilms LC, Beetstra SAJN, Heijnen CGM, Voss HP, Bast A. Interactions between flavonoids and proteins: effect on the total antioxidant capacity. J Agric Food Chem 2002; 50: 1184-1187.
40. Kim AR, Park MJ, Lee MK, Sung SH, Park EJ, Kim J, Kim SY, Oh TH, Markelonis J, Kim YC. Flavonoids of Inula Britanica protect cultured cortical cells from cecrotic cell death induced by glutamate. Free Rad Biol Med 2002; 32: 596-604.
41. Van Acker FAA, Hulshof JW, aenen GRMM, Menge WMPB, Van der Vijgh WJF, Bast A. New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity. Free Rad Biol Med 2001; 31: 31-37.
42. Wachowicz B, Szwarocka A. Response of pig blood platelets to cisplatin and sodium selenite: lipid peroxidation and oxygen radical generation. Biomed Lett 1994; 49: 147-152.